---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-22-026776"
form_type: "8-K"
ticker: "ASTC"
cik: "0001001907"
company_name: "ASTROTECH Corp"
filed_at: "2022-11-10T23:59:59+00:00"
generated_at: "2026-06-21T22:00:44.837042+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Astrotech reports Q1 FY2023 revenue of $38K, authorizes $1M share repurchase

## Summary
- Revenue $38K for Q1 FY2023, down from prior year due to shift from ETD to AgLAB-1000-D2 commercialization.
- Cash and liquid investments total $48.9M, supporting R&D, organic growth, and potential acquisitions.
- Board authorized $1M share repurchase program from Nov 17, 2022 through Nov 17, 2023.
- BreathTech subsidiary contracts clinical research firm to collect breath samples; BreathTest-1000 shows discrimination ability.
- AgLAB-1000-D2 field trials promising; first production run started and sales efforts underway.

## SEC filing metadata
- accession: 0001437749-22-026776
- form_type: 8-K
- ticker: ASTC
- cik: 0001001907
- company_name: ASTROTECH Corp
- filed_at: 2022-11-10T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1001907/000143774922026776/0001437749-22-026776-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1001907/000143774922026776/astc20221107_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-22-026776
- JSON: https://secwatch.observer/filing/0001437749-22-026776.json
- Plain text: https://secwatch.observer/filing/0001437749-22-026776.txt

## Key facts
- Earnings Releases
  ASTROTECH Corp reported first quarter of fiscal year 2023, which ended September 30, 2022 results: revenue $38 thousand.
  - Period: first quarter of fiscal year 2023, which ended September 30, 2022
  - Revenue: $38 thousand
  - Result: reported results
  source text: Revenue for the quarter totaled $38 thousand and was mainly related to ongoing maintenance services and sales of consumables for the TRACER 1000TM explosive trace detector (ETD).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1001907/000143774922026776/0001437749-22-026776-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.
